WO2009133610A1 - 疼痛処置用皮膚貼付具 - Google Patents
疼痛処置用皮膚貼付具 Download PDFInfo
- Publication number
- WO2009133610A1 WO2009133610A1 PCT/JP2008/058281 JP2008058281W WO2009133610A1 WO 2009133610 A1 WO2009133610 A1 WO 2009133610A1 JP 2008058281 W JP2008058281 W JP 2008058281W WO 2009133610 A1 WO2009133610 A1 WO 2009133610A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pain
- patch
- particle size
- pressing
- tenderness
- Prior art date
Links
- 208000002193 Pain Diseases 0.000 title claims abstract description 188
- 230000036407 pain Effects 0.000 title claims abstract description 182
- 239000007933 dermal patch Substances 0.000 title claims description 11
- 239000004575 stone Substances 0.000 claims abstract description 79
- 238000003825 pressing Methods 0.000 claims abstract description 57
- 229910052751 metal Inorganic materials 0.000 claims abstract description 21
- 239000002184 metal Substances 0.000 claims abstract description 21
- 239000002923 metal particle Substances 0.000 claims description 71
- 239000002245 particle Substances 0.000 claims description 43
- 229910001111 Fine metal Inorganic materials 0.000 claims description 21
- 230000001225 therapeutic effect Effects 0.000 abstract description 12
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- 210000003811 finger Anatomy 0.000 description 38
- 210000005036 nerve Anatomy 0.000 description 32
- 238000000034 method Methods 0.000 description 24
- 210000003205 muscle Anatomy 0.000 description 20
- 230000005856 abnormality Effects 0.000 description 17
- 229910052500 inorganic mineral Inorganic materials 0.000 description 15
- 239000011707 mineral Substances 0.000 description 15
- 208000006820 Arthralgia Diseases 0.000 description 14
- 150000002500 ions Chemical class 0.000 description 14
- 230000001070 adhesive effect Effects 0.000 description 13
- 230000006378 damage Effects 0.000 description 13
- 239000000853 adhesive Substances 0.000 description 12
- 208000024765 knee pain Diseases 0.000 description 12
- 230000006866 deterioration Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 239000012790 adhesive layer Substances 0.000 description 8
- 230000001684 chronic effect Effects 0.000 description 8
- 238000007596 consolidation process Methods 0.000 description 8
- 210000003127 knee Anatomy 0.000 description 8
- 239000011435 rock Substances 0.000 description 8
- 230000008034 disappearance Effects 0.000 description 7
- 231100000862 numbness Toxicity 0.000 description 7
- 230000035807 sensation Effects 0.000 description 7
- 208000030090 Acute Disease Diseases 0.000 description 6
- 208000034656 Contusions Diseases 0.000 description 6
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000008717 functional decline Effects 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000001953 sensory effect Effects 0.000 description 6
- 208000017667 Chronic Disease Diseases 0.000 description 5
- 208000010040 Sprains and Strains Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000008451 emotion Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000008733 trauma Effects 0.000 description 5
- 208000008035 Back Pain Diseases 0.000 description 4
- 208000000094 Chronic Pain Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 210000000689 upper leg Anatomy 0.000 description 4
- 206010049949 Intercostal neuralgia Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 3
- 206010028836 Neck pain Diseases 0.000 description 3
- 208000008765 Sciatica Diseases 0.000 description 3
- 208000007613 Shoulder Pain Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 210000000245 forearm Anatomy 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 208000004296 neuralgia Diseases 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 210000003813 thumb Anatomy 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 208000002881 Colic Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 235000019738 Limestone Nutrition 0.000 description 2
- 206010024995 Lumbar hernia Diseases 0.000 description 2
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 210000000467 autonomic pathway Anatomy 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 208000034526 bruise Diseases 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 210000004394 hip joint Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 239000006028 limestone Substances 0.000 description 2
- 210000004932 little finger Anatomy 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001330002 Bambuseae Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010065433 Ligament rupture Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 206010064584 Myosclerosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010060932 Postoperative adhesion Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010043248 Tendon rupture Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000001264 anterior cruciate ligament Anatomy 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 208000022371 chronic pain syndrome Diseases 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000024764 elbow pain Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000002425 internal capsule Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000001991 scapula Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 208000037911 visceral disease Diseases 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H1/00—Apparatus for passive exercising; Vibrating apparatus; Chiropractic devices, e.g. body impacting devices, external devices for briefly extending or aligning unbroken bones
- A61H1/008—Apparatus for applying pressure or blows almost perpendicular to the body or limb axis, e.g. chiropractic devices for repositioning vertebrae, correcting deformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0048—Detecting, measuring or recording by applying mechanical forces or stimuli
- A61B5/0053—Detecting, measuring or recording by applying mechanical forces or stimuli by applying pressure, e.g. compression, indentation, palpation, grasping, gauging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4824—Touch or pain perception evaluation
- A61B5/4827—Touch or pain perception evaluation assessing touch sensitivity, e.g. for evaluation of pain threshold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/023—Adhesive bandages or dressings wound covering film layers without a fluid retention layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0273—Adhesive bandages for winding around limb, trunk or head, e.g. cohesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00919—Plasters containing means for physical therapy, e.g. cold or magnetic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00936—Plasters containing means metal
Definitions
- the present invention finds that there is a map-like boundary line and / or induration in the range of tenderness on the skin as a cause of pain, and uses and presses a pressing bar or a finger (mainly a thumb). Clarify the cause of pain, determine whether the category is tenderness, caking, or whether there is tenderness and causality, and press with metal particles or crushed stones according to the treatment method
- the present invention relates to a patch treatment device for pain treatment that enables dramatic pain improvement.
- nerve abnormalities and functional deterioration occur in the human body.
- nerves may be damaged by external factors such as sprains.
- these nerve abnormalities, functional declines, and damages also disrupt the muscle management, resulting in muscle deterioration and muscle fiber hardening. Pain occurs due to these nerve abnormalities, reduced function, damage and muscle stiffness.
- these nerve abnormalities, functional decline, damage, and muscle hardening may be shallow and narrow, or wide and deep. Therefore, in order to eliminate pain, it is necessary to improve nerve abnormalities, functional decline, damage, muscle hardening, etc. according to the symptoms.
- Simple improvement means include massage, rest, cooling, compression, and elevation.
- Massage massages “crust”, which is a hardened part.
- Resting is a static measure for the tissue to recover by fixing the damaged part or preventing the risk of causing damage.
- Cooling is a method in which a cold pack or ice pack is applied to the periphery of an affected area to contract blood vessels.
- Pressure aims to rest by fixing the painful part.
- “Raising” raises the injury site, promotes blood flow back to the heart, and reduces fluid retention.
- these improvement means only expect natural healing power based on the human body, and it takes a long time to be completely cured. In some cases, it may cause chronicity.
- a skin patch treatment tool that can be used at home.
- An adhesive treatment tool that adheres to the skin is known (Patent Document 1).
- This sticking treatment tool is applied to the meridians and acupoints of the human body, so that the thermal action of far infrared rays and the energy of negative ions generated by the polymer granular ore in the center of the sheet are directly applied to the meridians and acupoints. It is intended to act.
- JP 2002-209973 JP 2002-209973
- the present invention finds that there is a map-like boundary line and / or induration in the tender range that is the cause of pain, and uses a pressing bar or fingers (first to fourth fingers) to press Or, by palpating, clarify the cause of pain, determine whether the category is tenderness or caking, or whether there is tenderness and caking, and use treatment methods according to the category with metal particles or crushed stone It is an object of the present invention to provide a patch treatment device for pain treatment that can dramatically improve pain by a compression method.
- the present inventors performed pressing using a pressing rod or fingers (first to fourth fingers) on an affected part (pain site) where a patient subjectively complains of pain.
- tenderness had a map-like shape instead of a point-like shape, and there was a boundary line (between the painful part and the non-feeling part).
- tenderness has depth and breadth, muscle stiffness has hardness and size, and there is a classification of pain cause by tenderness and stiffness.
- this invention consists of the following. 1.
- One side where a plurality of fine metal particles with a particle size of 0.1 to 1.8 mm or a plurality of crushed stones with a particle size of 0.5 to 3 mm are attached to the surface in a state of covering the entire tenderness area and / or hardening confirmed by pressing
- a skin patch for treating pain comprising a sheet-like patch A of 5 to 15 cm.
- One or two metal grains with a particle size of 3 to 10 mm or multiple crushed stones with a particle diameter of 1 to 5 mm in a state of covering the entire tenderness area and / or induration confirmed by pressing is converted into metal grains or crushed stones.
- a skin patch for treating pain wherein a plurality of sheet-like patches B having a maximum length of 1.5 to 3 cm attached to the surface are bonded so as to overlap each other.
- Affixing tool A with multiple fine metal particles or crushed stone attached to the surface is applied to the tenderness range and / or induration confirmed by pressing in a state of covering the whole, and then the painful part and / or induration
- One or two metal particles having a diameter of 3 to 10 mm or a plurality of crushed stones having a particle size of 1 to 5 mm are attached to the surface, and the maximum length is 1.5 to 3 cm.
- the skin patch for pain treatment according to item 3 comprising a kit including the patch A and the patch B. 5).
- the size of the multiple fine metal particles of the patch A is 0.1 to 1.8 mm, the interval is 0 to 12 mm, the fine metal particles are arranged in a lattice shape, or the particle size of the crushed stone of the paste A is
- Crushed stone with a particle size of 0.5 to 3 mm, crushed stone with a particle size of 1 to 5 mm, a sheet-like member with a side of 5 to 15 cm with a patch applied, and a sheet with a maximum length of 1.5 to 3 cm with a patch applied comprising a kit comprising a member. 11.1) Confirm tenderness range by pressing with a pressing rod or finger; 2) Apply in a state covering the entire confirmed tender area; A plurality of fine metal particles having a particle diameter of 0.1 to 1.8 mm or a plurality of crushed stones having a particle diameter of 0.5 to 3 mm attached to the surface is 5 to 15 cm on one side Use of the sheet-like patch A for pain treatment.
- Confirm tenderness range and / or induration by pressing with a pressing rod or finger 2) Affix multiple sheets in a state that covers the confirmed tenderness range and / or the entire induration; 1 or 2 metal particles having a particle size of 3 to 10 mm or a plurality of crushed stones having a particle size of 1 to 5 mm with a metal particle or crushed stone attached to the surface. Of pain treatment.
- a 1% risk rate means 99% probability of reliability.
- similar therapeutic effects were observed for pain in other parts of the body (Table 2).
- the nerve is effectively and quickly Abnormalities and functional deterioration, recovery of damage (the tender part, that is, the pain of pressing is completely disappeared) and the hardening of the muscle is thawed and recovered to a flexible muscle, and the pain and other symptoms associated therewith are eliminated and improved Made it possible to do.
- the pain according to the present invention refers to pain that is subjectively felt by a patient and that occurs in any part of the body.
- Psychological internal factors such as excessive stress, busy overwork, pain of visceral diseases such as cancer, and pain caused by external factors such as sprains, bruises, fractures, post-fracture treatment, postoperative adhesion pain I mean.
- knee pain general neuralgia, sports disorders / trauma, shoulder and peripheral pain, lower back hernia, ankle sprain, chronic headache, migraine, neck and shoulder pain, intra-elbow pain, hip joint pain, intercostal neuralgia, It can cope with all kinds of pain. It includes cases of chronic diseases, acute diseases, and chronic acute diseases that occur regardless of age, sex, fatness, thinness, etc.
- Chronic disease refers to a condition that occurs continuously or intermittently for 6 months or more after the appearance of pain (International Chronic Pain Society). Sensory symptoms such as pain, weight, stiffness, rash, vine, numbness, and discomfort are phenomena that occur due to lack of blood flow depending on the degree of nerve function decline (blocking of nerve transmission, etc.), and cause of chronic diseases It is also.
- An acute disease refers to a disease in which pain occurs rapidly in a short time. Chronic acute disease is pain that occurs continuously or intermittently, but the degree of pain is weak and not so much of a concern. It refers to the disease that occurs.
- the treatment of the present invention is to find the range boundary line and induration (deteriorated muscle) of tenderness, which is the cause of pain found by the present inventor, and apply the patch treatment tool for pain treatment of the present invention.
- the skin surface of a healthy human body always has a negative biopotential, but when a nerve abnormality, functional decline, or damage occurs, the biopotential of that portion is converted from negative to positive.
- tenderness and induration which cause pain in the nerves, are created, and pain, weight, numbness, stiffness, convulsions, discomfort, etc. are considered to occur depending on the degree of nerve function deterioration.
- the pressing of the present invention refers to pressing a pain site where a patient subjectively claims pain with a stick or fingers (first to fourth fingers) shown in FIG.
- the degree of pressing force is determined so that pain can be recognized while confirming with the patient. Moreover, it is preferable to carry out in such an extent that the affected part is not burdened while considering the symptoms. It has been found that tenderness and / or induration is always present at a pain site where a patient subjectively claims pain.
- a pressure bar is essential to clearly determine the area where pressure is strong and the finger can not be pressed due to muscle tension, the narrow place where the finger is difficult to enter, and the tenderness boundary line,
- the first finger to the fourth finger of the fingers may be used to determine the hardness of the consolidation or its magnitude.
- the pressing rod of the present invention refers to a pressing rod having a spherical, hemispherical, or spherical shape with a diameter of 4 to 8 mm, a length of 20 to 25 cm, a circumference of 42 mm, and a weight of 85 g to 100 g.
- FIG. 7 shows one of the most suitable ones. Optimal means that if there is no weight to some extent, deep tenderness cannot be found, and if it is longer or shorter, the operation will be hindered. The same is true if the hand is too thick or too thin.
- the pressing bar has a diameter of 5 mm at the front end, a diameter of 7 mm at the rear end, a length of 23 cm, and a weight of 85 g.
- the spherical, hemispherical, or spherical shape is preferable because it hardly damages the skin or the like, can concentrate the pressing force at one point, and can easily communicate the cause of pain and the depth of tenderness.
- the reason why a diameter of 4 to 8 mm is preferable is that the tender site can be accurately grasped.
- 7 mm at the rear end is preferable, but in order to catch a slight gap between overlapping metal particles or to confirm a deeper part, about 5 mm at the front end is preferable. If the length is too long or short, it is difficult to use. Also, things that are too light or heavy are difficult to use.
- the rod shown in FIG. 7 is made of metal, but may be other than metal. Further, when a muscle hardness meter or the like is provided on the pressing bar, an objective index can be displayed to the patient as pain decreases. Such a pressing bar is not used at all except by the inventors.
- the pain site of the present invention refers to a site where a patient subjectively complains of pain and other symptoms, and there is always tenderness and / or induration in the pain site, but there are other cases where this is not the case. For example, if there is pain in the front of the knee and the whole area, there is cakingness as a pain cause category on the back of the knee, and there is a cause of tenderness in the upper part of the affected neck for numbness pain from the internal capsule of the forearm to the little finger. Numbness from the outside of the forearm to the thumb, pain is tenderness around the cervical vertebra, pain in the front of the thigh, numbness, coldness, etc. cause painful pain around the lumbar 4 and 5 affected side Exists.
- the pain cause of the present invention refers to an inductive objective pain site.
- the cause of detailed pain has not been elucidated (International Chronic Pain Society), but when the cause of pain according to the present invention is broadly divided, by pressing using a pressing bar or finger (first to fourth fingers),
- tenderness a method of pulling out pain by pressing the affected area and searching for the cause of pain clearly
- caking a method of objectively searching for the cause of pain due to hardening due to muscle deterioration, etc.
- the pain cause classification according to the present invention is one of tenderness, inductively using a pressure bar, 1 to feel strong pain due to slight pressure (rubbing with a pressure bar, rolling), to some extent (balloons) The degree to which you feel pain by pressing the pressure (can be pushed and depressed not to break) 3; That is.
- the other is a method of objectively knowing the cause of pain in patients who are hardened, but this is the hardness of muscle hardening that has become harder due to the sensation (feel) of the fingers (first to fourth fingers) by palpation. Or it distinguishes the size. These are broadly classified into tenderness and caking.
- the tenderness of the present invention refers to an abnormal sensory nerve pain sensation of the autonomic nerve and is considered to cause pain due to an abnormality of the sensory nerve.
- the tender range of the present invention refers to the entire tender site and the boundary line.
- the tender range is easy to understand given the bruised condition.
- the range and boundary of tenderness varies depending on the shape of the bruised object, such as a ball or bamboo sword.
- the depth of damage varies depending on the strength of the impact.
- the subjective symptoms are also reduced in proportion to the reduction in tenderness. That is, reduction or disappearance of tenderness is a relief and disappearance of subjective pain, and tenderness (nerve abnormality) is considered to be the cause of pain.
- these applications will be applied to tenderness other than bruise. From the aspect of recurrence, as long as these tenderness remains, it is not a complete cure, and even if the pain disappears temporarily, recurrence can be considered.
- the induration of the present invention is considered to be caused by a decrease in function of nerves that manage these muscles due to abnormal somatic nerves and the inability to supply blood flow to the muscles.
- the hardness of muscle consolidation also varies depending on the age. At later ages, muscle induration is as hard, thick, and large as the formation, but it has been confirmed that it thaws several times.
- Achilles tendon rupture, anterior cruciate ligament rupture, flesh separation, cramping, convulsions, fifty shoulders, etc. are phenomena that occur when muscles, tendons, and ligaments begin to harden and harden.
- the boundary line of the present invention refers to the boundary between a painful part and a painless part by inducing pain by inductively pressing.
- the boundary line of the tenderness range By clarifying the boundary line of the tenderness range, it is possible to know the subjective pain appealed by the patient as objective information. Moreover, the existence of these objective pains has been found by the present inventor and is unparalleled at present.
- FIG. 8 shows an example in which a borderline and a pain portion where a particularly strong pain is felt are confirmed. Marked with a pen etc. that can be used directly on the body. In addition, the pain part that felt particularly tenderness was marked as large by a circle.
- FIG. 9 is also an example in which the boundary line and consolidation are confirmed in the same manner. The large enclosed area is the boundary line, and the small enclosed area is hardened.
- A shows before the application of the treatment tool of the present invention, and B shows after the application.
- Nerve function deterioration of the present invention refers to a nerve as an electrical transmission path, a case where the amount of electricity supplied is 100 as a healthy state, and a state of decreasing to 80, 60, 50, 40 is referred to as nerve function deterioration. .
- the degree of functional deterioration refers to a state in which the functional deterioration of nerves is made constant. In proportion to this, a lack of blood flow occurs, which is considered to be the cause of induration and tenderness that are also the cause of chronic pain diseases.
- the sticking tool A of the present invention includes a pressure-sensitive adhesive sheet 13 in which a plurality of metal particles 12 are arranged at predetermined intervals on the pressure-sensitive adhesive layer 11 that is one side of the sheet member 10, and positions corresponding to the metal particles 12.
- a small hole 14 is provided, and each metal particle 12 protrudes from each small hole 14 and includes a release sheet 15 that can be peeled off from the adhesive layer 11 (FIGS. 1 and 2).
- the sheet member 10 is made of paper, nonwoven fabric, cloth, or flexible resin sheet having strength and flexibility.
- the thickness is 1 mm or less.
- an adhesive layer 11 is provided by applying an adhesive.
- the adhesive layer 11 may be formed by previously bonding and fixing a plurality of metal particles 12 to a sheet member and applying an adhesive to the surface.
- the size can be any size as long as it can be applied to the entire range of tenderness and / or induration on the skin surface of the human body. For example, one side is 5 to 15 cm square and economically about 8 to 10 cm square. Or the thing of a rectangle is preferable also from the response
- the color is preferably a color that is inconspicuous on the skin.
- the release sheet 15 is made of a sheet of paper or resin having flexibility, flexibility and strength. One side is treated so that it can be easily peeled off from the adhesive layer 11. A plurality of small holes 14 are provided so as to correspond to the arrangement positions of the plurality of metal particles 12.
- the fine metal particles are made of metal, and the metal is iron, copper, chromium, gold, silver, lead, tin, aluminum, stainless steel, germanium, titanium, or the like. . Any metal having any composition may be used as long as the bioelectric potential of the skin can be converted by the mineral ions generated from the fine metal particles.
- the particle size is about 0.1 to 1.8 mm. If it is less than 0.1 mm, it is too small to reduce the pressure acting on the skin, and a sufficient effect cannot be expected. Moreover, if it is 1.8 mm or more, it is too large, and when used, it may bite into the human skin and cause discomfort.
- the metal particle is easily peeled off.
- an uncomfortable feeling of strangeness continues due to the size of the grains due to the weight of the soles and the like, resulting in stress.
- hemispherical, cylindrical shape, polygonal pyramid shape, etc. are not specifically limited.
- the amount of ions emitted differs depending on the size and shape of the metal particles. Information was collected from more than 15,000 patients and made the best shape and size.
- the mineral ions generated by the arrangement of the fine metal particles can be even and can reach the deep part.
- the arrangement of a plurality of fine metal particles is an arrangement in which the intervals between the plurality of fine metal particles are raised in a lattice shape of 0 to 12 mm.
- the interval between the plurality of fine metal particles is 4 to 8 mm.
- the thickness is preferably 4 to 8 mm. These distance intervals depend on the size and hardness of consolidation, the depth of tenderness, the shallowness, and the like.
- the raw material of the crushed stone that may be used with a crushed stone is preferably a sedimentary rock (clastic rock (sandstone, conglomerate, mudstone, shale, etc.), volcanic clastic rock (tuff, etc.). It is prepared from those containing minerals such as biological rock (chart, limestone, etc.).
- a crushed stone having a particle size of 0.5 to 3 mm, preferably 0.9 to 2.5 mm can be used. In the case of crushed stones, it is sufficient to arrange the crushed stones randomly. Of course, the diameter of the crushed stone is adjusted, and it does not prevent the same arrangement as the fine metal particles.
- the sticking tool B of the present invention comprises an adhesive sheet 23 provided with metal particles 22 on an adhesive layer 21 that is one side of a sheet member 20, and a release sheet 24 that can be peeled from the adhesive layer 21 (FIG. 3, 4, 5, 6).
- the sheet member 20 is made of the same material as the sheet member 10 of FIG.
- the size may be any size as long as it can be affixed to the skin of a human body, but if it is too small, there will be few contact surfaces with the skin and it will be easy to peel off, and if it is too large, it will not be good in terms of cost.
- the color is preferably a color that matches the skin in terms of patient privacy.
- the release sheet 24 is made of the same material as the release sheet 15 in FIG.
- the metal particles (the metal particles 22 in FIGS. 3, 4, 5 and 6) of the sticking tool B are made of the same material as the fine metal particles (the metal particles 12 in FIGS. 1 and 2).
- the particle size is 3 to 10 mm, preferably 5 to 10 mm, and the height is about 1 to 5 mm.
- FIG. 3 shows the shape of a regular quadrangular pyramid. One side 31 of the bottom surface is 5 to 10 mm, and the height is 1 to 5 mm.
- this shape does not have to be a regular quadrangular pyramid, and is not particularly limited to a spherical shape, a hemispherical shape, a cylindrical shape, a polygonal pyramid shape, a disc shape, an egg-shaped disc, a pyramid shape, a sword tip shape, a needle tip shape, etc. Absent. If you have magnetism, the pyramid type, sword tip type, and needle tip type are recommended to maintain the shape. There is no particular limitation as long as the particles exclude magnetic properties. Preferably, the ions generated from the metal grains are only required to be able to reach evenly and deeply.
- the crushed stone may be interspersed with the patch B of the present invention.
- the raw material for crushed stones preferably contains minerals such as sedimentary rocks (clastic rocks (sandstone, conglomerate, mudstone, shale, etc.), volcanic clastic rocks (tuff, etc.), biological rocks (chart, limestone, etc.), etc. Prepared.
- a crushed stone having a particle size of 1 to 5 mm, preferably about 1.5 to 3 mm can be used. In the case of crushed stones, it is sufficient to arrange the crushed stones randomly. Of course, adjusting the diameter of the crushed stone does not prevent the arrangement of about 1 to 6 pieces like the above metal grains.
- the kit including the patch A and the patch B of the present invention includes the patch A and the patch B defined above.
- other materials used for pain treatment such as a pressing rod and a replacement sheet member, can be included.
- the stone is non-magnetic. If there is magnetism, stones may combine and curl up when the sheet is rolled up.
- the kit including a crushed stone and a sheet member coated with a patch includes a crushed stone and a sheet member coated with a patch.
- the release sheet 10 or 20, a stick for pressing, and the like used for pain treatment can be included.
- the particle size of the crushed stone is differentiated as in the above-mentioned patch A and B, and the smaller one (0.5-3mm) and the larger one (1.5-3mm) are sealed, and the sheet for the patch A and the patch B
- a kit comprising a sheet can be provided.
- the case where the treatment tool A of the present invention is used is a case where tenderness (nerve) is wide and shallow and damaged or deteriorated in function.
- it is used for acute diseases, acute trauma, disordered diseases, neuralgia and the like. More preferably, it is used for trauma caused by sprains or bruises, intercostal neuralgia, sciatica, colic, knee pain, back pain, stiff shoulders, and the like.
- the method of using the treatment tool A first confirms the tenderness range and the boundary line by pressing using a stick or a finger (mainly the thumb) (see FIG. 8).
- the treatment tool A is peeled off the release sheet 15, and the sheet member 10 is pasted up to the boundary line of the entire tender range so that the metal particles 12 or the crushed stone are in contact with the skin surface. At this time, the treatment tool A is appropriately cut to a size suitable for the boundary line.
- the method of using the treatment tool A is shown in FIG.
- the case where the treatment tool B of the present invention is used is a case where the tenderness is deep (depth of nerve abnormalities) and the hardened portion has hardness and is large. In these cases, multiple sheets are used with no gaps. It has been confirmed that even a gap of only about 5 mm may cause pain.
- Preferably used for chronic diseases, etc. but preferably chronic pain due to chronic sprains or bruises, chronic intercostal neuralgia and shingles, chronic sciatica, chronic (crush pain, knee pain, low back pain, (Stiff shoulders, neck pain, fifty shoulders, shoulder pain, headache, tired eyes, pain in the back, etc.) Used severely for neck, lumbar hernia, etc.
- the treatment tool B is used by first confirming the tenderness range and the boundary line that cause the pain and / or induration by pressing with a stick or a finger (first to fourth fingers) (FIGS. 8 and 9). reference). Next, the treatment tool B is peeled off the release sheet 24, and the sheet member 20 is pasted so that the metal particles 22 or the crushed stone are in contact with the skin surface. At this time, the treatment tool B is pasted up to the entire boundary of the tender range or on the hardened body, and a plurality of sheets are laminated so as to cover the whole hardened body, and the adjacent metal particles 22 or crushed stones are pasted as much as possible. . (See FIG. 6). In this case, the metal particles 22 or crushed stone may not be in direct contact with the skin.
- the case where the treatment tool A and the treatment tool B of the present invention are used in combination is a case where tenderness (nerve abnormality) exists widely and shallowly, and a case where a hard constriction exists within the tenderness range.
- it is used for general organ pain, chronic acute disease, chronic disease, acute trauma, disordered disease and the like. More preferably, there are widespread tenderness such as trauma caused by sprains or bruises, sciatica, colic, knee pain, low back pain, stiff shoulders, etc.
- Pain may remain between the metal particles, and therefore the treatment tool B is stuck between the intervals.
- the effect of mineral ions is narrower, the installation surface with the skin increases and the mineral ion effect is maximized.
- the treatment tool A and the treatment tool B in combination, first, by using a stick or a finger (first finger to fourth finger) to the tender pain range boundary line causing pain and / or confirming induration (See FIGS. 8 and 9).
- the treatment tool A is peeled off the release sheet 15 and the sheet member 10 is pasted up to the tender range boundary line and the entire consolidation so that the metal particles 12 or the crushed stone are in contact with the skin surface.
- the treatment tool A is appropriately applied to the range of tenderness up to the boundary line, but if it is wide, several pieces can be used, and the remainder can be cut for other use. The most important thing is to stick to the boundary of the entire tender area.
- the treatment device B is pasted on the portion (see FIG. 8, see FIG. This makes it possible to take pain accurately and more reliably.
- the metal particles 22 or crushed stone may not be in direct contact with the skin. Even if the adjacent metal particles 22 or crushed stone do not directly contact the surface of the skin, the mineral ions from each metal particle 22 or crushed stone permeate the sheet member 20 by the sheet member 20 of the adjacent treatment tool B. Therefore, even if there is tenderness and / or induration to the deep part, the induration is thawed and even deep nerve abnormalities can be recovered.
- Method of treatment There are 40 patients with knee pain each in the gold group and the gold group, and the treatment site is the tenderness range and induration around the knee and thigh in both the gold group and the gold group, and the treatment method is low frequency, massage each Only 10 minutes and the presence or absence of metal grains.
- the treatment method was made constant.
- a metal-free particle group was set as a control group, and the difference in therapeutic effect was examined by carrying out under exactly the same conditions as the metal group.
- the treatment period was 3 consecutive days, and the evaluation was made by statistical analysis between the two groups using VAS (visual analyze scale), and judged with a risk rate of 1% or less.
- the VAS of knee pain patients was the average after pre-treatment for 3 days from the pre-treatment average of 65.8 ⁇ 8.4 in the funded group of the present invention (average age: 56.9 years old, male / female; 13/27)
- the therapeutic effect was recognized with a significant difference of 14.3 ⁇ 12.0 (P ⁇ 0.01).
- the non-money group mean age; 45.0 years old, male / female; 11/29
- the average from 63.5 ⁇ 10.4 before treatment to 45.6 ⁇ 10.3 after 3 consecutive days
- the treatment of attaching the metal particles used for the metallized group up to the tender pain range boundary line and / or the entire induration for knee pain was sufficiently effective.
- substantially the same effect was confirmed using titanium, germanium, and stainless steel.
- Table 2 shows the results of pain in other parts of the body, the same as with knee pain. Similar to knee pain, the treatment of attaching the metal particles used in the clinical group 1 gold group up to the tender range boundary line and / or the entire induration was sufficiently effective (Table 2). Look at the significant difference in data in Table 2 and the data after treatment for lumbar hernia.
- the recurrence rate was 7 (26%) and the cure rate was 20 (74%) among 27 patients.
- the cure rate was 20 (74%) among 27 patients.
- 22,4% of people whose pain has been relieved by the conventional treatment method 77,6% unchanged, and 17 million subjects (Japanese Journal of Chronic Pain VOL. 25 NO. 1 2006. P40 Miyazaki) This is a remarkable effect and a low rate of recurrence.
- adhesive tool B cone particles (gold-plated iron) at the center of a circular sheet with a diameter of about 3cm, sticking a maximum diameter of 5mm and height of 2mm
- Adjacent and pasted so as not to leave a gap as much as possible. Pain alleviated immediately after application, and as a result of continuing application for 1 week, the pain in the lower back was relieved. About 6 months later, she returned to the hospital, but there was no recurrence.
- the treatment tool B using crushed stone in the pain part is overlapped and covered so as to cover the entire hardened part, Affixed so as not to leave a gap as much as possible. Pain alleviated immediately after application, and as a result of continuing application for 1 week, pain in the knee was completely relieved. About 6 months later, she returned to the hospital, but there was no recurrence.
- VAS and MDS data analysis Pain relieving test by applying metal particles with treatment tool B so as not to leave gaps as much as possible, overlapping and covering the entire pain generation area (maximum edge: boundary)
- VAS Visual Analog Scale (minimum 0%, maximum 100%)
- MDS Multi Dimentional Scale Information provided by Supermedical Research Institute Kazuyoshi Sakamoto, Professor Emeritus, National University of Electro-Communications Patients in their teens to 70s were treated in order of visit, and the relationship between MDS pain (sensory, emotion, evaluation) and level and VAS was investigated.
- Therapeutic sites include neck pain for 22 cases, shoulder pain (including scapula) 16 cases, upper limb (upper arm to finger) 6 cases, back pain 23 cases, buttocks pain (including hip joint pain) 9 cases, lower limb (large Thigh to foot pain) 32 cases, a total of 108 cases.
- VAS before and after treatment (first time) VAS mean value, before treatment 73,3 after treatment 20,4 VAS standard deviation value, before treatment 18,1 after treatment 23,5 (Fig. 13A) Before and after treatment VAS (third time) VAS The results were as follows: average value, 6,0 before treatment, 1,9 VAS standard deviation value, 16,9 before treatment, and 5,9 after treatment (FIG. 13B). The level of sensation, emotion and evaluation by MDS is shown in 1 to 5 levels.
- the treatment period of pain can be shortened and recurrence can be prevented, the economic and physical burden on the patient can be reduced, and medical costs can be reduced.
- the patch A, the patch B, and the combination of the patch A and the patch B of the present invention are small and lightweight, they are convenient to carry when participating in sports or travel. In addition, it is easy to keep in the first aid kit at home. Since the metal particles of the present invention can be used semi-permanently, when the adhesive strength of the sheet member is reduced, it can be reused using a new sheet member.
- FIG. 3 is a sectional view taken along line AA in FIG. 2.
- FIG. 4 is a usage diagram illustrating a plurality of sticking tools B according to the present invention. A pressing bar is shown. The borderline and the pain part that felt pain in particular are shown. Shown inside and outside the knee. Shows boundaries and consolidation. The usage method of the sticking tool A is shown. The usage method of the sticking tool B is shown. The usage method which combined the sticking tool A and the sticking tool B is shown.
- Fig. A shows VAS before and after treatment (first time)
- Fig. B shows VAS before and after treatment (third time).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rehabilitation Therapy (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Finger-Pressure Massage (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
さらに、これらの神経の異常や機能低下、損傷により、筋肉の管理にも乱れが生じ、その結果、筋肉が劣化し、筋肉繊維が硬化する。
これらの神経の異常や機能低下、損傷及び筋肉の硬化により、痛みが発生する。
また、これらの神経の異常や機能低下、損傷及び筋肉の硬化は、浅く狭いこともあれば、広く深いこともある。従って、痛みを解消させるには、神経の異常や機能低下、損傷及び筋肉の硬化等を、その症状にあわせて改善する必要がある。
「マッサージ」は、硬結部分である「こり」を揉みほぐすものである。
「安静」は、損傷部を固定したり、損傷を招くリスクを防止したりして、組織が回復に向かうための静的な措置である。
「冷却」は、コールドパックやアイスパックを患部の周辺に当て、血管を収縮させるものである。
「圧迫」は、痛む部位を固定することで、安静を図るものである。
「挙上」は、損傷部位を高く上げ、心臓へと戻る血流を促し、体液の貯留を軽減するものである。
しかし、これらの改善手段は、人体に基づく自然治癒力を期待するだけであって、完治するまでに長期間を要する。また、場合によっては、慢性化を引き起こす原因ともなる。
この貼付治療具は、人体の経絡やツボに貼付することで、シート中心部にある重合粒状物の鉱石材等が発生する遠赤外線の熱作用とマイナスイオンのエネルギーが、直接、経絡やツボに作用することを目的とするものである。
1.押圧によって確認された圧痛範囲及び/又は硬結に、その全体を覆う状態で、粒径が0.1~1.8mmの複数微小金属粒又は粒径が0.5~3mmの複数砕石を表面に付着させた1辺が5~15cmのシート状貼付具Aを、貼付することを特徴とする疼痛処置用皮膚貼付具。
2.押圧によって確認された圧痛範囲及び/又は硬結に、その全体を覆う状態で、粒径が3~10mmの1又は2個の金属粒又は粒径が1~5mmの複数砕石が金属粒又は砕石を表面に付着させた最大長が1.5~3cmのシート状貼付具Bを、重なり合い隣接するように複数枚貼付することを特徴とする疼痛処置用皮膚貼付具。
3.押圧によって確認された圧痛範囲及び/又は硬結に、その全体を覆う状態で、複数微小金属粒又は砕石を表面に付着させた貼付具Aを貼付し、ついで、疼痛部及び/又は硬結に、粒径が3~10mmの1又は2個の金属粒又は粒径が1~5mmの複数砕石が金属粒又は砕石を表面に付着させた最大長が1.5~3cmのシート状貼付具Bを貼付具Aの上から、1枚又は複数枚貼付する、請求項1に記載の疼痛処置用皮膚貼付具。
4.前記貼付具Aと前記貼付具Bとを含むキットからなる、前項3に記載の疼痛処置用皮膚貼付具。
5.押圧棒又は指を用いた押圧により、地図状に広がった圧痛範囲及び/又は硬結を確認する、請求項1~4のいずれか一に記載の疼痛処置用皮膚貼付具。
6.押圧棒の両端が球状、半球状又は球面状の直径4~8mm、長さが20~25cm、重さ85g~100gである、前項5に記載の疼痛処置用皮膚貼付具。
7.貼付具Aの複数微小金属粒の粒径が0.1~1.8mmであり、粒間が0~12mmである、格子状に微小金属粒が配列されてなる、又は貼付具Aの砕石の粒径が0.5~3mmであり、砕石がランダムに散りばめるように配置されてなる、請求項1~6のいずれか一に記載の疼痛処置用皮膚貼付具。
8.貼付具Bの金属粒の粒径が3~10mmであり、高さが1~5mmである請求項2~6のいずれか一に記載の疼痛処置用皮膚貼付具。
9.貼付具Bの砕石の粒径が直径1~5mmであり、砕石がランダムに散りばめるように配置されてなる、請求項2~6のいずれか一に記載の疼痛処置用皮膚貼付具。
10.粒径が0.5~3mmの砕石、粒径が1~5mmの砕石、貼付剤が塗布された1辺が5~15cmのシート状部材、及び貼付剤が塗布された最大長が1.5~3cmのシート状部材とを含むキットからなる、請求項1~6のいずれか一に記載の疼痛処置用皮膚貼付具。
11.1)押圧棒又は指を用いた押圧により、圧痛範囲を確認し;
2)確認された圧痛範囲全体を覆う状態で貼付する;
ことを含む請求項1~10のいずれか一に記載の粒径が0.1~1.8mmの複数微小金属粒又は粒径が0.5~3mmの複数砕石を表面に付着させた1辺が5~15cmのシート状貼付具Aの、疼痛処置のための用途。
12.1)押圧棒又は指を用いた押圧により、圧痛範囲及び/又は硬結を確認し;
2)確認された圧痛範囲及び/又は硬結の全体を覆う状態で、複数枚貼付する;
ことを含む粒径が3~10mmの1又は2個の金属粒又は粒径が1~5mmの複数砕石が金属粒又は砕石を表面に付着させた最大長が1.5~3cmのシート状貼付具Bの、疼痛処置のための用途。
13.1)押圧棒又は指を用いた押圧により、圧痛範囲及び/又は硬結を確認し;
2)確認された圧痛範囲及び/又は硬結の全体を覆う状態で、粒径が0.1~1.8mmの複数微小金属粒又は粒径が0.5~3mmの複数砕石を表面に付着させた1辺が5~15cmのシート状貼付具A貼付し;ついで
3)疼痛部及び硬結に、粒径が3~10mmの1又は2個の金属粒又は粒径が1~5mmの複数砕石が金属粒又は砕石を表面に付着させた最大長が1.5~3cmのシート状貼付具Bを貼付具Aの上から、1枚又は複数枚貼付する;
ことを含む前記貼付具A及び貼付具Bの、疼痛処置のための用途。
また、疼痛原因の区分に応じた処置方法(圧痛性には主に治療用具A、硬結性には主に治療用具B、その両方が存在する場合は治療用具Aと治療用具Bの組み合わせ)で、その圧痛範囲境界線まで及び/又は硬結の全体を金属粒又は砕石で圧迫する。また膝痛患者において、VAS(visual analyze scale)が、治療前平均65.8±8.4から3日間連続治療後平均14.3±12.0危険率1%未満をもって治療効果を認めた。ここで危険率1%とは99%の確率で起こりえる信頼性を意味する。
さらに体のその他の部位における痛みについても、同様の治療効果が認められた(表2)。
これにより、患者が主観的に訴える痛みが生じている部分と、客観的に痛みが発生する原因となっている部分との、ズレが生じている場合であっても、効果的かつ迅速に神経の異常や機能低下、損傷の回復(圧痛部分即ち、押圧しての痛みを完全消失する)及び筋肉の硬化を解凍し柔軟な筋肉に回復させ、それに伴う痛み、その他諸症状を消失させ、改善することを可能とした。
さらに詳しくは、膝痛、神経痛全般、スポーツ障害・外傷、肩関節及び周辺痛、腰ヘルニア、足関節捻挫、慢性頭痛、偏頭痛、首肩周辺痛、肘内外側痛、股関節痛、肋間神経痛、等あらゆる痛みに対応することができる。
老若、男女、太っている、痩せている等に関係なく生じる慢性的疾患、急性的疾患、慢性的急性疾患いずれの場合も含む。
急性的疾患とは、痛みが急激に短時間の間に生じる疾患をいう。
慢性的急性疾患とは、痛みが継続的又は断続的に生じているが、痛みの程度が弱く、あまり気にならない程度であったが、ある動作を境に、急激にそれ以上の強い痛みが生じる疾患をいう。
健康な人体の皮膚表面には、常にマイナスの生体電位があるが、神経の異常や機能低下、損傷が生じると、その部分の生体電位が、マイナスからプラスに変換する。同時に神経の機能低下を招き疼痛原因である圧痛及び硬結がつくり出され、痛み、重み、痺れ、凝り、攣り、違和感等が、その神経の機能低下度合いにより発生すると考えられる。
従って、その部分にミネラルを有する金属粒体を、皮膚上から貼り付け、圧迫することにより、ミネラルイオンが皮膚に伝わり、また浸透して生体電位を正常なマイナスの状態に変換することができる。これにより、神経の異常や機能低下、損傷が回復し、痛み、その他諸症状が改善すると考えられている(特開2002-209973号、昭61-15703号)。
また、金属粒の代わりに本発明では砕石であっても、同様の効果が生じる。
患者が主観的に痛みを主張する疼痛部位には、圧痛及び/又は硬結が必ず存在することを見出している。しかし圧痛を探すのに筋肉の張りにより指の力では押すことのできない強圧する部位や指が入りにくい狭い場所、また圧痛性の境界線を鮮明に判定するには押圧棒は必須であるし、また硬結の硬度或いは、その大小を見極めるには指の第1指~第4指を用いるとよい。
好ましくは、先端が直径5mm、後端が直径7mm、長さが23センチ、重さが85gである押圧棒である。
球状、半球状又は球面状のものが好ましいのは、皮膚等を傷つけることが少ないし、一点に押す力を集中でき、痛みの原因、圧痛の深さに対してコミュニケーションをとりやすいためである。
直径4~8mmのものが好ましいのは、圧痛部位を的確にとらえることができるためである。通常、圧痛を探す場合は後端の7mmがいいが、重なり合う金属粒子のわずかな隙間を捕らえたり、より深い部位を確認したりするためには、先端の5mm前後が好ましい。
長さはあまり長いもの、短いものでは、使いにくい。また、あまり軽いもの、重すぎるものも使いにくい。図7で示した棒は金属でできているが、金属以外でもいい。
さらに、この押圧棒に筋硬度計等を備え付けると、痛みの低下とともに、患者に客観的指数を表示することができる。
このような押圧棒は、本発明者等以外では、全く使用されていない。
圧痛範囲は、打撲した状態を考えると理解しやすい。打撲は、ボールや竹刀等、ぶつけた物の形状によって、圧痛の範囲や境界線が違う。また、ぶつけた強さにより、損傷の深さも異なる。打撲が治癒する経過において、圧痛の軽減に比例して、自覚症状も緩和する。つまり、圧痛の軽減、又は消失が自覚痛緩和、消失であり、圧痛(神経異常)が疼痛の原因となっていると考えられている。圧痛は感覚神経の異常により、疼痛を引き起こしていると考えられているため、これら神経を回復させることが、圧痛消失=疼痛(自覚痛)を消失させることであり、再発の無い治癒につながるものである。
これと同様に、打撲以外で生じた圧痛にも、これら応用が適用されることになる。また再発面から考えると、これら圧痛が残存する限り、完全な治癒ではなく、一時的に痛みは消失しても再発が考えられるのである。
寸法は人体の皮膚表面の圧痛範囲及び/又は硬結の全体に貼り付けることができれば、どの様な大きさでもよいが、例えば1辺が5~15cm、経済的には8~10cm四方程度の正方形又は長方形のものが、体の各部位への対応やコスト的にも好ましい。使用時は、患部に対応する大きさに切断が可能である。色は患者のプライバシー等の面から、あまり目立たない肌にあった色が好ましい。
粒径は0.1~1.8mm程度である。0.1mm以下では小さすぎて皮膚への圧迫作用が減少し、十分な効果を期待できない。また、1.8mm以上では大きすぎて使用時に、人体の皮膚に食い込み、不快感が生じることがある。具体的には、大きな金属粒だと、手足の指、踵、足裏等、狭小部は検者が貼りにくいし、患者が作業等に影響があり邪魔になり、金属粒がはがれやすい。また足裏など体重がかかることで粒の大きさにより不快な異和感が継続しストレスとなる。
球状のものが望ましいが、半球状、円柱状、多角錐状等、特に形状に限定されるものではない。
ただし、金属粒の大きさ、形でイオンの発する量が違う。1万5千例以上の患者から、情報を収集し、最良の形、大きさのものとした。
好ましくは、それらの微小金属粒の配列により発生するミネラルイオンが、均等かつ深部にまで到達することができるものであればいい。
ミネラルイオンの効果は間隔が狭い程、肌との設置面が多くミネラルイオン効果を最大限に発揮する。皮膚面に対し、金属粒を特殊的に貼付する際、圧痛の深さ等又は、硬結の硬度や大きさ等により、金属粒子間にわずか数ミリの隙間の存在により痛みの解消に影響があるため、隙間ができるだけ無いほうがいい。また若年者等により硬結の硬度が無かったり、小さいもの又、圧痛に深さが無く、広く浅い場合はその限りではない。
前記間隔が0mmであれば、隣り合う微小金属粒が接触状態であり、効率的に指圧効果とミネラルイオンを発生することができる。ただし、粘着効果がなくなり金属粒が浮いてしまうことがある。このため、好ましくは4~8mmとした。また、これら距離間隔は硬結の大小や硬度、圧痛の深さ、浅さ等によるものである。
また、実験結果から12mm以下であれば、自覚痛の消失を確認できたが、12mm以上であれば、隣り合う金属粒体の間隔が長すぎるので、ミネラルイオンを均等に発することができず、完全な痛みの消失は確認できなかった。
寸法は、人体の皮膚に貼り付けることができる寸法であればどの様な大きさでもよいが、小さ過ぎると皮膚への接触面が少なく剥がれ易いし、大きすぎるとコストの面で良くない。最大長が1.5~3cm程度のシート、好ましくは直径が2~3cm程度のシートで、端がめくれないよう円形が好ましい。
色は、患者のプライバシー等の面から肌に合った色が好ましい。
粒径は3~10mm、好ましくは5~10mmであり、高さが1~5mm程度である。
図3では、正四角錐の形状を示した。底面の一辺31が5~10mm、高さが1~5mmである。しかし、この形状は、正四角錐でなくてもよく、球状、半球状、円柱状、多角錐状、円盤状、卵型円盤、ピラミッド型、剣先型、針先型等、特に限定されるものではない。磁性を持っている場合は、形状維持のためピラミッド型、剣先型、針先型がこのましい。磁性を排除した粒子であれば、特に限定されない。
好ましくは、この金属粒から発生するイオンが、均等かつ深部にまで到達することが可能なものであればいい。
好ましくは、石は磁性がないものがいい。磁性があると石同士が結合してシートがくるくると丸まってしまうことがある。
治療用具Aの使用方法は、まず、棒又は指(主に母指)を使った押圧により、圧痛範囲と境界線を確認する(図8参照)。
次いで、治療用具Aを、剥離シート15を剥がして、シート部材10を、金属粒体12又は砕石が皮膚面に接触するようにして、圧痛範囲全体の境界線まで貼り付ける。
この際、治療用具Aは、適宜、境界線に合った寸法に切断して使用する。
治療用具Aの使用方法は図10に示した。
治療用具Bの使用方法は、まず、棒又は指(第1指~第4指)を使った押圧により、疼痛原因である圧痛範囲及び境界線まで/又は硬結を確認する(図8、図9参照)。
次いで、治療用具Bを、剥離シート24を剥がして、シート部材20を、金属粒体22又は砕石が皮膚面に接触するようにして貼り付ける。
この際、治療用具Bは、圧痛範囲全体境界線まで又は硬結上に、重合させて硬結全体を覆うように複数枚を貼り合わせるとともに、隣り合う金属粒体22又は砕石をできるだけ接触させて貼付する。(図6参照)。 この場合、直接皮膚に金属粒体22又は砕石が接触しなくてもいい。隣接する金属粒体22又は砕石は、皮膚の表面に直接接触しなくても、隣接する治療用具Bのシート部材20によって、各金属粒体22又は砕石からのミネラルイオンが、シート部材20を透過する(部材20の透過は本発明者が見出したものであり、今までは鉱物が直接皮膚に貼付されていた、またこの貼付方法の開発が、より完全な除痛効果を可能にしたことはいうまでもない)ため、皮膚の表面に作用することができ、深部まで圧痛及び/又は硬く、大きな硬結があった場合でも、それを解凍し回復することができる。
治療用具Bの使用方法は図11に示した。
治療用具Aと治療用具Bを組み合わせた使用方法は、まず、棒又は指(第1指~第4指)を使った押圧により、疼痛原因である圧痛範囲境界線まで及び/又は硬結を確認する(図8、図9参照)。次いで、治療用具Aを、剥離シート15を剥がして、シート部材10を、金属粒体12又は砕石が皮膚面に接触するようにして、圧痛範囲境界線まで及び硬結の全体に貼り付ける。
この際、治療用具Aは、適宜、境界線までの圧痛範囲に貼付するが、広い場合は何枚か使用し、余りは切断して他に使用できる。一番大事なことは圧痛範囲全体の境界線まで貼付することである。さらに、治療用具Aの上から、押圧をした際に確認しておいた、患者が特に強い痛みを訴える疼痛部又は硬結部分があった場合、その部分に重ねて治療用具Bを貼り付ける(図8、図9参照)。これにより正確、より確実に痛みを取ることができる。
この場合、直接皮膚に金属粒体22又は砕石が接触しなくてもいい。隣接する金属粒体22又は砕石は、皮膚の表面に直接接触しなくても、隣接する治療用具Bのシート部材20によって、各金属粒体22又は砕石からのミネラルイオンが、シート部材20を透過するため、皮膚の表面に作用することができ、深部まで圧痛及び/又は硬結があった場合でも、硬結を解凍し、深部の神経異常までも回復することができる。
治療用具Bのみを複数枚重ねて貼付した場合と比較しても同様の効果があり、コスト面を考慮すると、約5倍~8倍の費用が節約できる。圧痛(神経異常)が広く、浅い場合は治療用具Bのみではコスト面にかなりの差が生じるため、これら治療用具A,Bの組み合わせが考案されたものである。治療用具Aと治療用具Bを組み合わせた使用方法は図12に示した。
尚、これら使用された治療用具の取り外すタイミングは治療用具A、2日前後、治療用具Bは3日前後、治療用具A,Bも同様であるが、大事なことは時間や日数に関係なく、かゆみ、チクチク感が継続的に出現した場合は取り外す。また、いずれの症状も出現しない場合はシート内にある金属粒及び、砕石をシート上から押してみてチクチク感があれば取り外す。なくても5日以内には衛生面から取り外すようにする。
(治療対象)
膝痛患者(慢性、急性含む)80名(平均年齢;50.9歳、男性/女性;24人/56人)をランダムに選出し、有金群(貼付具B:約3.5cmの円形シートの中心に最大径5mm高さ2mmの多角錘で金属として金メッキ鉄を使った)と無金群の分類を無作為に行った。
膝痛患者を有金群、無金群各40名とし、施術部位は有金群、無金群ともに膝周辺及び大腿部に存在する圧痛範囲及び硬結とし、処置方法は低周波、マッサージ各10分と金属粒の有無のみとした。膝痛に対する治療効果を客観的に評価する為、治療方法を一定にした。また、コントロール群として無金属粒子群を設定し、有金属群と全く同じ条件下で行うことで、治療効果の違いを検討した。
治療期間は3日間連続で行い、評価はVAS(visual analyze scale)を用いて、2群間を統計解析し、危険率1%以下で判定した。
膝痛患者のVASは本発明の有金群(平均年齢;56.9歳、男性/女性;13人/27人)が、治療前平均65.8±8.4から3日間連続治療後平均14.3±12.0と、有意差をもって治療効果を認めた(P<0.01)。
無金群(平均年齢;45.0歳、男性/女性;11人/29人)は、治療前平均63.5±10.4から3日間連続治療後平均45.6±10.3であり、有意差は認められなかった。
以上のことから、膝痛に対して、有金群に用いた金属粒を圧痛範囲境界線まで及び/又は硬結の全体に貼り付ける処置は、十分に効果が認められた。なお、金以外にも、チタン、ゲルマニウム、ステンレスを使い略同様の効果を確認した。
体のその他の部位における痛みについて、膝痛と同様に実施した結果を表2に示す。
膝痛と同様、臨床例1有金群に用いた金属粒を圧痛範囲境界線まで及び/又は硬結の全体に貼り付ける処置は、十分に効果が認められた(表2)。表2のデータ有意差1%及び腰ヘルニア治療後データをみよ。
再発防止度とは、圧痛の消失、硬結の完全解凍をいう。ただし、硬結の場合は、存在しても使用頻度により、痛みは出現しない。硬結部分に過剰な負荷がかからない限り痛みとして出現しないためである。また痛み(自覚痛)が軽減しても強い圧痛が残存している場合、そこで処置を中止したときは再発する可能性が高かった。圧痛は指だけではなく、棒で強く押してもまったく痛くない状態になった時は再発がなかった。
臨床例4及び5に示した。本発明の治療方法により、患者27名中、再発率7名(26%)治癒率20名(74%)であった。これは、従来の治療方法で痛みが和らいでいる人22,4%、不変77,6%、対象1700万人(日本慢性疼痛学会誌VOL.25 NO.1 2006.P40宮崎)、に比べると、著しい効果であり、再発率の低い割合である。
腰の疼痛をうったえた患者(40歳代、女性)を、押圧棒(図7)と指による押圧によって図9Aに示す圧痛範囲最大縁(境界線)と硬結部を特定し、そこに本発明の貼付具A〔12cmX7cmの長方形シートに約8mm間隔で格子状に約1.3mm径の半円盤状微小粒子(金メッキ鉄)を粘着〕を使い境界線全体を覆うように複数シートをつかって皮膚表面に貼付させた。さらに、硬結部に貼付具B〔直径約3cmの円形シートの中心に円錐粒子(金メッキ鉄)で、最大径5mm高さ2mmを粘着〕を使い尖端側を硬結部全体を覆う様に重ね合わせて隣接させ、可能な限り隙間をあけないように貼付した。貼付後ただちに疼痛が軽減し、貼付を1週間継続した結果、腰の疼痛は全快した。約6ヶ月後に、再来院したが、再発はなかった。
膝の疼痛をうったえた患者(年齢5?歳、女性)を、押圧棒(図7)と指による押圧によって図8に示す最大縁(境界線)と強い痛みを感じる疼痛部を特定し、そこに本発明の砕石を使った治療用具A〔12cmX7cmの長方形シートにランダムに一面に約1~2mm径の砕石(堆積石)を粘着〕を使い境界線全体を覆うように複数シートをつかって皮膚表面に貼付させた。さらに、疼痛部に砕石を使った治療用具B〔直径約4cmの円形シートの中心に径2~5mmの砕石(堆積石)を粘着〕を使い硬結部全体を覆う様に重ね合わせて隣接させ、可能な限り隙間をあけないように貼付した。貼付後ただちに疼痛が軽減し、貼付を1週間継続した結果、膝の疼痛は全快した。約6ヶ月後に、再来院したが、再発はなかった。
VAS と MDS データ解析:痛み発生領域(最大縁:境界線)の全体を覆う様に重ね合わせて隣接させ、可能な限り隙間をあけないように治療用具Bによる金属粒子の貼付による痛み解消試験
VAS: Visual Analog Scale(最低0%、 最大100%)
MDS: Multi Dimentional Scale
資料提供スーパーメディカル研究所 解析 国立電気通信大学名誉教授 坂本和義
(治療対象)
来院患者10代~70代を来院順に治療し、MDS痛みの側面(感覚、情動、評価)及びレベル と VAS との関係を調査した。
治療部位は痛みを対象とした頚部痛22例、肩痛(肩甲骨含)16例、上肢(上腕部~手指)6例、腰痛23例、臀部痛(股関節痛含)9例、下肢(大腿部~足部痛)32例、合計108例とした。
治療前後のVAS(1回目) VAS平均値、治療前73,3治療後20,4 VAS標準偏差値、治療前18,1治療後23,5(図13A) 治療前後のVAS(3回目) VAS平均値、治療前6,0治療後1,9 VAS標準偏差値、治療前16,9 治療後5,9(図13B)という結果となった。またMDSによる感覚、情動、評価のレベルは、1~5段階で示した。 感覚(1熱い、しびれる2チクチク3刺すような4やけるような5引っ張る痛み) 情動(2ぞっとする 3怖い、不安4恐れおののく 5死ぬほど辛い) 評価(2イライラ3強烈な4耐え難い5苦しみもだえる) 治療前1回目総合感覚159、総合情動29、総合評価30 治療後3回目 総合感覚13、総合情動6、総合評価0という結果となった。このことから患者の自覚痛消失に伴い精神的苦痛が和らぎ内面的ケアをも可能としていることがわかった。またVASだけでは分からなかった実際の痛みと異なり、感覚的、情動的痛みが存在することが分かった。長期間、痛みと共に共存していた患者に多く、実質的には痛みは無いが、痛い気がするとか、また痛みが出現してくるのではないかという不安、また痛みが急激に消失して脳感覚が連動しにくいといった現象が起こっているのではないかと思われた。
これにより、患者が主観的に訴える痛みが生じている部分と、客観的に痛みが発生する原因となっている部分との、ズレが生じている場合であっても、効果的かつ迅速に神経の異常や機能低下、損傷及び筋肉の硬化を回復させ、それに伴う痛み、その他諸症状を改善することが可能となった。
従って、疼痛の治療期間を短縮し、再発を防ぐことができ、患者に対する経済的、肉体的負担が軽減され、医療費の節減にもつながるものと考えられる。
また、本発明の貼付具A、貼付具B、及び貼付具Aと貼付具Bの組み合わせは、小型、軽量であるため、スポーツ又は旅行等に参加するときには、携帯に便利である。さらに、家庭では救急箱に入るので、保管しやすい。
本発明の金属粒体は半永久的に使用することができるので、シート部材の粘着力が低下した場合に、新たなシート部材を使用して再利用することができる。
10 シート部材
10a シート部材の片面
11 粘着層
12 金属粒体
13 粘着シート
14 小孔
15 剥離シート
2 貼付具B
20 シート部材
21 粘着層
22 金属粒体
23 粘着シート
24 剥離シート
31 金属粒体の辺
32 頂点
33 側面
Claims (13)
- 押圧によって確認された圧痛範囲及び/又は硬結に、その全体を覆う状態で、粒径が0.1~1.8mmの複数微小金属粒又は粒径が0.5~3mmの複数砕石を表面に付着させた1辺が5~15cmのシート状貼付具Aを、貼付することを特徴とする疼痛処置用皮膚貼付具。
- 押圧によって確認された圧痛範囲及び/又は硬結に、その全体を覆う状態で、粒径が3~10mmの1又は2個の金属粒又は粒径が1~5mmの複数砕石が金属粒又は砕石を表面に付着させた最大長が1.5~3cmのシート状貼付具Bを、重なり合い隣接するように複数枚貼付することを特徴とする疼痛処置用皮膚貼付具。
- 押圧によって確認された圧痛範囲及び/又は硬結に、その全体を覆う状態で、複数微小金属粒又は砕石を表面に付着させた貼付具Aを貼付し、ついで、疼痛部及び/又は硬結に、粒径が3~10mmの1又は2個の金属粒又は粒径が1~5mmの複数砕石が金属粒又は砕石を表面に付着させた最大長が1.5~3cmのシート状貼付具Bを貼付具Aの上から、1枚又は複数枚貼付する、請求項1に記載の疼痛処置用皮膚貼付具。
- 前記貼付具Aと前記貼付具Bとを含むキットからなる、前項3に記載の疼痛処置用皮膚貼付具。
- 押圧棒又は指を用いた押圧により、地図状に広がった圧痛範囲及び/又は硬結を確認する、請求項1~4のいずれか一に記載の疼痛処置用皮膚貼付具。
- 押圧棒の両端が球状、半球状又は球面状の直径4~8mm、長さが20~25cm、重さ85g~100gである、前項5に記載の疼痛処置用皮膚貼付具。
- 貼付具Aの複数微小金属粒の粒径が0.1~1.8mmであり、粒間が0~12mmである、格子状に微小金属粒が配列されてなる、又は貼付具Aの砕石の粒径が0.5~3mmであり、砕石がランダムに散りばめるように配置されてなる、請求項1~6のいずれか一に記載の疼痛処置用皮膚貼付具。
- 貼付具Bの金属粒の粒径が3~10mmであり、高さが1~5mmである請求項2~6のいずれか一に記載の疼痛処置用皮膚貼付具。
- 貼付具Bの砕石の粒径が直径1~5mmであり、砕石がランダムに散りばめるように配置されてなる、請求項2~6のいずれか一に記載の疼痛処置用皮膚貼付具。
- 粒径が0.5~3mmの砕石、粒径が1~5mmの砕石、貼付剤が塗布された1辺が5~15cmのシート状部材、及び貼付剤が塗布された最大長が1.5~3cmのシート状部材とを含むキットからなる、請求項1~6のいずれか一に記載の疼痛処置用皮膚貼付具。
- 1)押圧棒又は指を用いた押圧により、圧痛範囲を確認し;
2)確認された圧痛範囲全体を覆う状態で貼付する;
ことを含む請求項1~10のいずれか一に記載の粒径が0.1~1.8mmの複数微小金属粒又は粒径が0.5~3mmの複数砕石を表面に付着させた1辺が5~15cmのシート状貼付具Aの、疼痛処置のための用途。 - 1)押圧棒又は指を用いた押圧により、圧痛範囲及び/又は硬結を確認し;
2)確認された圧痛範囲及び/又は硬結の全体を覆う状態で、複数枚貼付する;
ことを含む粒径が3~10mmの1又は2個の金属粒又は粒径が1~5mmの複数砕石が金属粒又は砕石を表面に付着させた最大長が1.5~3cmのシート状貼付具Bの、疼痛処置のための用途。 - 1)押圧棒又は指を用いた押圧により、圧痛範囲及び/又は硬結を確認し;
2)確認された圧痛範囲及び/又は硬結の全体を覆う状態で、粒径が0.1~1.8mmの複数微小金属粒又は粒径が0.5~3mmの複数砕石を表面に付着させた1辺が5~15cmのシート状貼付具A貼付し;ついで
3)疼痛部及び硬結に、粒径が3~10mmの1又は2個の金属粒又は粒径が1~5mmの複数砕石が金属粒又は砕石を表面に付着させた最大長が1.5~3cmのシート状貼付具Bを貼付具Aの上から、1枚又は複数枚貼付する;
ことを含む前記貼付具A及び貼付具Bの、疼痛処置のための用途。
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010509973A JP5340272B2 (ja) | 2008-04-30 | 2008-04-30 | 疼痛処置用皮膚貼付具 |
PCT/JP2008/058281 WO2009133610A1 (ja) | 2008-04-30 | 2008-04-30 | 疼痛処置用皮膚貼付具 |
US12/988,686 US8827966B2 (en) | 2008-04-30 | 2008-04-30 | Skin patch instrument for treating pain |
US14/322,946 US20140316457A1 (en) | 2008-04-30 | 2014-07-03 | Skin Patch Instrument For Treating Pain |
US14/322,948 US20140364760A1 (en) | 2008-04-30 | 2014-07-03 | Skin Patch Instrument For Treating Pain |
US15/364,549 US20170079867A1 (en) | 2008-04-30 | 2016-11-30 | Skin Patch Instrument For Treating Pain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2008/058281 WO2009133610A1 (ja) | 2008-04-30 | 2008-04-30 | 疼痛処置用皮膚貼付具 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/988,686 A-371-Of-International US8827966B2 (en) | 2008-04-30 | 2008-04-30 | Skin patch instrument for treating pain |
US14/322,948 Continuation US20140364760A1 (en) | 2008-04-30 | 2014-07-03 | Skin Patch Instrument For Treating Pain |
US14/322,946 Continuation US20140316457A1 (en) | 2008-04-30 | 2014-07-03 | Skin Patch Instrument For Treating Pain |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009133610A1 true WO2009133610A1 (ja) | 2009-11-05 |
Family
ID=41254841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/058281 WO2009133610A1 (ja) | 2008-04-30 | 2008-04-30 | 疼痛処置用皮膚貼付具 |
Country Status (3)
Country | Link |
---|---|
US (4) | US8827966B2 (ja) |
JP (1) | JP5340272B2 (ja) |
WO (1) | WO2009133610A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
WO2011017489A1 (en) * | 2009-08-05 | 2011-02-10 | Tyco Healthcare Group Lp | Surgical wound dressing incorporating connected hydrogel beads having an embedded electrode therein |
US11786455B2 (en) | 2011-05-10 | 2023-10-17 | Itochu Chemical Frontier Corporation | Non-aqueous patch |
SI2823815T1 (sl) * | 2011-09-27 | 2018-09-28 | Itochu Chemical Frontier Corporation | Ne-vodni obliž |
EP2698136A1 (de) * | 2012-08-17 | 2014-02-19 | Gordon Teigelkämper | Kosmetikpflaster |
US20160101141A1 (en) * | 2014-10-14 | 2016-04-14 | Topical Biomedics, Inc. | Topical Treatment of Sports Related Injuries |
US20240115460A1 (en) * | 2022-10-06 | 2024-04-11 | Propio Poynts, LLC | System and method for stimulating and applying pressure to points on a human body |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63188033U (ja) * | 1987-05-26 | 1988-12-01 | ||
JPH03114239U (ja) * | 1990-03-06 | 1991-11-22 | ||
JPH1099406A (ja) * | 1996-09-27 | 1998-04-21 | Yasushi Fujimori | 粒状物体を保持する粘着テープ |
JP2004275750A (ja) * | 2003-02-24 | 2004-10-07 | Tatsuzo Nakamura | 治療用器具 |
JP2005087495A (ja) * | 2003-09-17 | 2005-04-07 | Toshimitsu Matsumoto | 人体押圧刺激具 |
JP3129267U (ja) * | 2006-11-06 | 2007-02-15 | 有限会社マイオセラピー | 指圧による筋肉の調整道具 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US423676A (en) * | 1890-03-18 | Horse-collar fastener | ||
DE423676C (de) * | 1924-07-11 | 1926-01-08 | Franz Burghauser Dipl Ing | Kraftmaschinenregler mit Hilfsmotor |
US4022189A (en) * | 1973-09-04 | 1977-05-10 | Steve Boxer | Device and processes for alleviation of muscular pain and stiffness, and symptoms of non-muscular ailments |
US3987787A (en) * | 1973-09-04 | 1976-10-26 | Steve Boxer | Process and device for alleviation of muscular and non-muscular pain and discomfort |
US3886939A (en) * | 1973-09-04 | 1975-06-03 | Steve Boxer | Device for alleviating muscular discomfort |
GB8823765D0 (en) * | 1988-10-11 | 1988-11-16 | Ici America Inc | Method & instrument |
US5531675A (en) * | 1989-05-10 | 1996-07-02 | Yoo; Tae W. | Micro-acupuncture needle for a finger of a hand |
JPH03129267A (ja) | 1989-10-10 | 1991-06-03 | Aisin Seiki Co Ltd | 空調機 |
USD344137S (en) * | 1989-12-14 | 1994-02-08 | Yoo Tae W | Acupressure stimulator |
USD351235S (en) * | 1990-02-21 | 1994-10-04 | Yoo Tae W | Acupressure stimulator |
US5250067A (en) * | 1992-11-30 | 1993-10-05 | Ala Gelfer | Body treatment pad having a multiple number of sharpened skin-penetration protuberances |
DE19511976A1 (de) * | 1995-04-02 | 1996-10-10 | Thomas Von Roenn | Pflaster |
US5624384A (en) * | 1995-05-04 | 1997-04-29 | Imei Chemical Enterprise Ltd. | Jade made massage-rod |
KR19980011842U (ko) * | 1996-08-23 | 1998-05-25 | 유태우 | 시계용 지압구 |
DE29621320U1 (de) * | 1996-12-07 | 1998-04-16 | Tjoa Ping Liong | Trainingsgerät |
US5792176A (en) * | 1996-12-09 | 1998-08-11 | Chang; Henry H. | Acupressure patch and method of use |
US5938684A (en) * | 1997-12-09 | 1999-08-17 | Sierra Self Healing Products, Inc. | Accupressure device for therapeutic relief |
US6241693B1 (en) * | 1998-04-30 | 2001-06-05 | Brian D. Lambden | Method and apparatus for applying acupressure |
US6030408A (en) * | 1998-10-22 | 2000-02-29 | East West Medical Llp | Acupressure treatment device |
USD423676S (en) * | 1999-02-09 | 2000-04-25 | Lazio Thomas F | Combined acupressure and massage device |
UA54480C2 (uk) * | 1999-07-15 | 2003-03-17 | Микола Григорович Ляпко | Аплікатор ляпка |
US6257785B1 (en) * | 1999-08-06 | 2001-07-10 | The Procter & Gamble Company | Semi-enclosed applicator utilizing a selectively-activatible sheet material for dispensing and dispersing a substance onto the surface of a target object |
USD435295S (en) * | 1999-08-30 | 2000-12-19 | Yoo Dong-Hoon | Acupuncture needles band for wrist of pilots |
US6316686B1 (en) * | 2000-06-20 | 2001-11-13 | Timothy N. Byrd | Medical pressure dressing and process |
US7828827B2 (en) * | 2002-05-24 | 2010-11-09 | Corium International, Inc. | Method of exfoliation of skin using closely-packed microstructures |
US20060015052A1 (en) * | 2004-07-15 | 2006-01-19 | Crisp William E | Wound dressing |
US7595066B2 (en) * | 2004-11-30 | 2009-09-29 | Jin Sub Kim | Composition having effect of moxibustion and press pellet using the same |
EA012358B1 (ru) * | 2005-07-20 | 2009-10-30 | Фрей Медикал Текнолоджис Аг | Способ пролонгированного воздействия на акупунктурные точки, в том числе для снижения избыточной массы тела и коррекции фигуры, устройство и игла (варианты) для него |
NZ577134A (en) * | 2006-10-25 | 2012-07-27 | Corey Philip Mouatt | An exercise apparatus with detachable parts and reconfigurable into different configurations, for massage, stretching or strength training |
US8608763B1 (en) * | 2009-10-15 | 2013-12-17 | SonicSurg Innovations, LLC | Method for minimally invasive tendon sheath release |
-
2008
- 2008-04-30 JP JP2010509973A patent/JP5340272B2/ja not_active Expired - Fee Related
- 2008-04-30 US US12/988,686 patent/US8827966B2/en active Active
- 2008-04-30 WO PCT/JP2008/058281 patent/WO2009133610A1/ja active Application Filing
-
2014
- 2014-07-03 US US14/322,946 patent/US20140316457A1/en not_active Abandoned
- 2014-07-03 US US14/322,948 patent/US20140364760A1/en not_active Abandoned
-
2016
- 2016-11-30 US US15/364,549 patent/US20170079867A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63188033U (ja) * | 1987-05-26 | 1988-12-01 | ||
JPH03114239U (ja) * | 1990-03-06 | 1991-11-22 | ||
JPH1099406A (ja) * | 1996-09-27 | 1998-04-21 | Yasushi Fujimori | 粒状物体を保持する粘着テープ |
JP2004275750A (ja) * | 2003-02-24 | 2004-10-07 | Tatsuzo Nakamura | 治療用器具 |
JP2005087495A (ja) * | 2003-09-17 | 2005-04-07 | Toshimitsu Matsumoto | 人体押圧刺激具 |
JP3129267U (ja) * | 2006-11-06 | 2007-02-15 | 有限会社マイオセラピー | 指圧による筋肉の調整道具 |
Also Published As
Publication number | Publication date |
---|---|
US8827966B2 (en) | 2014-09-09 |
JPWO2009133610A1 (ja) | 2011-08-25 |
JP5340272B2 (ja) | 2013-11-13 |
US20140316457A1 (en) | 2014-10-23 |
US20110046580A1 (en) | 2011-02-24 |
US20170079867A1 (en) | 2017-03-23 |
US20140364760A1 (en) | 2014-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5340272B2 (ja) | 疼痛処置用皮膚貼付具 | |
Han et al. | The effects of extracorporeal shock wave therapy on pain, disability, and depression of chronic low back pain patients | |
US10625092B2 (en) | Magnetic devices | |
JPH11164870A (ja) | 治療器具 | |
CN102908442A (zh) | 治疗跌打损伤的组合物及其药酒 | |
Chen et al. | The antalgic effects of non-invasive physical modalities on central post-stroke pain: a systematic review | |
Anaya-Terroba et al. | Effects of ice massage on pressure pain thresholds and electromyography activity postexercise: a randomized controlled crossover study | |
Yanbin et al. | Treatment of chronic plantar fasciitis with percutaneous latticed plantar fasciotomy | |
Lee et al. | Single-blinded, randomized preliminary study evaluating the effect of transcutaneous electrical nerve stimulation on postoperative pain in patients with colles' fracture | |
Etri et al. | Effects of acupressure on pain and vital signs of patients following small abdominal surgeries: A clinical trial | |
Dobreci et al. | The effects of extracorporeal shockwave therapy (ESWT) in treating lateral epicondylitis in people between 40 and 50 years old | |
CN102125641B (zh) | 一种治疗腰椎间盘突出的外用药物 | |
Haryadi et al. | Effectiveness of kinesio taping compared with short wave diathermy on pain perception and functional status in knee osteoarthritis patients | |
CN203169401U (zh) | 激痛点理疗法治疗仪 | |
Shandles et al. | Heel neuroma: the enigma of recalcitrant heel pain and an innovative approach highlighting sixty surgical cases and a review of two hundred and fifty-seven symptomatic but non-surgical cases | |
Pawluk | Pain management with pulsed electromagnetic field (PEMF) treatment | |
Ahalya | A Comparative Evaluation of Agnikarma and Upanaha in Pain Management in Janu Sandhigata Vata | |
RU2139069C1 (ru) | Средство для лечения патологических состояний "астромеланин"/"астронэлла") | |
Wamontree et al. | Effects of traditional Thai self-massage using a massage stick versus Ibuprofen on upper back pain associated with myofascial trigger points: a pilot study | |
CN106419360A (zh) | 一种治疗颈椎病的崖柏木药枕 | |
Gao et al. | Clinical Study of Acupotomy Trinity Lysis on Cervical Spondylotic Myelopathy with Liver and Kidney Deficiency Syndrome | |
Meti et al. | A COMPARATIVE CLINICAL STUDY OF THE EFFECT OF SHASTHIKASHALI PINDA SWEDANA AND INFRARED RADIATION THERAPY ON JANUSANDHIGATA VATA WSR TO KNEE JOINT OSTEOARTHRITIS | |
Crăciun | Improving the quality of life in climax with kinetotherapy and natural factors in Vatra Dornei resort | |
JP5348894B2 (ja) | 石鹸の芳香成分パッチ並びに筋肉の痙攣及び痛みの治療法 | |
DE202011103469U1 (de) | Kinesiologisches Tape |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08740949 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010509973 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12988686 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08740949 Country of ref document: EP Kind code of ref document: A1 |